BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 27, 2001
View Archived Issues
PDL grants license to Celltech for humanized anti-TNF antibodies
Read More
Xenon Genetics discovers two new drug targets for metabolic and neurological diseases
Read More
Worldwide expansion of Merck/Schering-Plough cholesterol partnership
Read More
Asimadoline alters cytokine gene expression in adjuvant arthritis
Read More
TAS-108 well tolerated and readily absorbed after oral dosing in preliminary clinical trial
Read More
CS-758: a new triazole antifungal agent with promise for candidiasis and aspergillosis
Read More
SkyePharma withdraws Solaraze termination notice
Read More
Cytovax files for approval to begin human trials of Cytovaxine
Read More
Clarinex cleared by FDA for SAR symptom relief, will be launched next month
Read More
New option for early-stage prostate cancer receives FDA clearance
Read More
Thalomid granted orphan drug status in Europe for multiple myeloma and ENL
Read More
Orally active growth hormone secretagogue SM-130686 identified by Sumitomo
Read More
Amgen initiates phase III AMG-073 trial for hyperparathyroidism
Read More
IL-12 gene therapy studied in Japan for inducing tumor immunity
Read More
Phase I trial initiated for antithrombotic drug candidate GH-9001
Read More
GSK discontinues development of ADL-2-1294
Read More
Potent new MMP inhibitor has excellent oral activity in a rat collagen degradation model
Read More
Forest submits NDA for oxycodone/ibuprofen to treat moderate to severe pain
Read More
Myriad Genetics seeks clearance for new clinical trial of Flurizan
Read More
Companies collaborate in developing neuroprotective compound DD-612
Read More
Superior efficacy of triple-antigen hepatitis B vaccine confirmed in inadequate responders
Read More
Avigen receives FDA approval to continue clinical trials for Coagulin-B gene therapy
Read More
New series from Bayer with excellent antiallergic activity
Read More
Lipase inhibitors produced by Streptomyces
Read More
CRF antagonists from a series of tricyclic fused pyrimidine and pyridine derivatives
Read More
Korean researchers identify new CDK inhibitors
Read More
Boston-based scientists disclose radiolabeled tumor imaging agents
Read More
